Business Courses

MicroRNAs, Exosomes, and Circulating Biomarkers: The Research Market, Diagnostics, and Therapeutics

This Business Course is being held in London, England on the 11 May 2012 at 12:15-14:15

Price:

Enal Razvi Managing Director, Select Biosciences Inc

This course is designed to provide a comprehensive analysis of the current state of the circulating biomarkers field focusing on microRNAs and circulating exosomes/microparticles. The focus here is upon the underlying science, emerging trends in technology development, the competitive environment, and market analysis.

Cancer Biomarkers	microRNAs	Exosomes
Classes of cancer biomarkers Biological Significance and Proposed Role In Vivo Utility of Expression Patterns/Signatures as a Determinant for Physiological Processes as well as Disease/Pathological Situations Examples of Expression Patterns and Correlations
Technologies for Studying microRNAs, Exosomes, and Other Classes of Circulating Biomarkers The Competitive Environment Market Metrics
Diagnostics Therapeutics

This training course is ideally suited for researchers involved in investigations focusing on microRNAs or other biomarker changes in biological and disease situations— both academic as well as from the industrial community. Also, this course is important for biotechnology, pharmaceutical, and related disciplines wherein industry participants—both technically focused as well as business focused—can get a solid understanding of the marketplace as well as receive the most up-to-date market data and associated materials for in-house research and business planning activities.  Also, this course is recommended for investors as well as attorneys looking for a current technology and market review of this expanding field.

All attendees to this training course receive the electronic files of the presentation material on disk with full rights to use them in their internal R&D as well as business planning activities.

Training Course Specific Presentation Topics

• MicroRNA Expression Profiles:  Biological Significance and Association with Disease Processes
• Technologies for Studying microRNA Expression Profiles and Function
• Technologies for Studying Exosomes and Microparticles
• Competitive Landscape of Research Tools and Technologies, Quantitative Market Penetrance
• Market Metrics
• Market Size
• Growth Rates
• Industry SWOT by Segment
• Association of Specific Signatures [microRNA Expression Profiles] with Specific Physiological or Pathological Events
• Cancer
• Cardiovascular Disease
• CNS Disease
• MicroRNAs  as Circulating Biomarkers
• Diagnostics
• Therapeutics
• Epigenetic Modifications as Circulating Biomarkers
• Development as Diagnostic Biomarkers
• Utility for Therapeutics Development

For more information about this training course or for group registrations, please e-mail Kathy Gray at Kathy.Gray@SelectBiosciences.com